Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-01-22 @ 8:53 AM
Study NCT ID:
NCT03425006
Status:
TERMINATED
Last Update Posted:
2023-09-13
First Post:
2018-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer
Sponsor:
University of Pennsylvania
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UPCC# 09517; IRB# 828910
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None